Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Meabco A/S in a privately held biotechnology company established in 2001 researching into breakthrough cancer therapy with the vision to create new effective cancer therapy options with low toxicity. The company has licensed all rights to two potential breakthrough cancer products which could significantly change the way cancer is being treated today. We are seeking to commercialize these products over the coming years as clin...
Meabco A/S in a privately held biotechnology company established in 2001 researching into breakthrough cancer therapy with the vision to create new effective cancer therapy options with low toxicity. The company has licensed all rights to two potential breakthrough cancer products which could significantly change the way cancer is being treated today. We are seeking to commercialize these products over the coming years as clinical research, physician experience and product registrations develops. Meabco A/S is managed from Copenhagen with a professional Board of Directors.

List your booth number for exhibitions, ask us